Turkmenistan vs Upper-middle income (World Bank): HPV immunization coverage estimates among primary target cohort (9-14)
Turkmenistan
95.0%
in 2025
Upper-middle income (World Bank)
32.0%
in 2025
Turkmenistan rank
9th
Upper-middle income (World Bank) rank
6th
HPV immunization coverage estimates among primary target cohort (9-14) over time
- Turkmenistan
- Upper-middle income (World Bank)
How they compare
Turkmenistan currently reports 95.0% against 32.0% in Upper-middle income (World Bank), a difference of 63.0%.
That makes Turkmenistan's figure about 3.0 times Upper-middle income (World Bank)'s.
Across all 10 years both countries report, Turkmenistan has been ahead every year.
Turkmenistan ranks 9th and Upper-middle income (World Bank) ranks 6th of 111 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Turkmenistan | Upper-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.8% | 20.8% | 75.0% | Turkmenistan |
| 2020s | 98.0% | 23.3% | 74.7% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv immunization coverage estimates among primary target cohort (9-14), Turkmenistan or Upper-middle income (World Bank)?
- Turkmenistan, at 95.0% against 32.0% in Upper-middle income (World Bank) as of 2025.
- What is the difference in hpv immunization coverage estimates among primary target cohort (9-14) between Turkmenistan and Upper-middle income (World Bank)?
- 63.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Turkmenistan and Upper-middle income (World Bank)?
- 10 years are reported by both, from 2016 to 2025.
- How do Turkmenistan and Upper-middle income (World Bank) rank globally for hpv immunization coverage estimates among primary target cohort (9-14)?
- Turkmenistan ranks 9th and Upper-middle income (World Bank) ranks 6th of 111 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.